vai alle Pubblicazioni
Pubblicazioni antecedenti il 2004
1. Zauli D, Baffoni L, Cassani F et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. Gastroenterology 1992;102:1088-1090.
2. Cassani F, Muratori L, Manotti P et al. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut. 1992;33:1260-1263.
3. Muratori L, Zauli D, Giostra F et al. LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. J Hepatol. 1993;18:259-260.
4. Gerotto M, Pontisso P, Giostra F et al. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol. 1994;21:273-276.
5. Muratori L, Lenzi M, Cataleta M et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 1994;21:199-203.
6. Muratori L, Giostra F, Cataleta M et al. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver. 1994;14:124-128.
7. Muratori L, Cataleta M, Muratori P et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods. 1995;187:259-264.
8. Muratori L, Lenzi M, Ma Y et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut. 1995;37:406-412.
9. Lenzi M, Manotti P, Muratori L et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 1995;36:749-754.
10. Bianchi FB, Cassani F, Lenzi M et al. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience. Dig Dis Sci. 1996;41:166-171.
11. Giostra F, Manzin A, Lenzi M et al. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. J Hepatol. 1996;25:433-438.
12. Bortolotti F, Vajro P, Balli F et al. Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol. 1996;25:614-620.
13. Muratori L, Gibellini D, Lenzi M et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood. 1996;88:2768-2774.
14. Zauli D, Ghetti S, Grassi A et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology. 1997;25:1105-1107.
15. Muratori P, Muratori L, Lenzi M, Bianchi FB. Antibodies to carbonic anhydrase in autoimmune cholangiopathy. Gastroenterology. 1997;112:1053-1054.
16. Sagnelli E, Stroffolini T, Ascione A et al. Decrease in HDV endemicity in Italy. J Hepatol. 1997;26:20-24.
17. Ma Y, Gregorio G, Gaken J et al. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J Hepatol. 1997;26:1396-1402.
18. Cassani F, Cataleta M, Valentini P et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 1997;26:561-566.
19. Volta U, De Franceschi L, Molinaro N et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190-2195.
20. Lenzi M, Frisoni M, Mantovani V et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood. 1998;91:2062-2066.
21. Muratori L. In situ reverse transcriptase-polymerase chain reaction: an innovative tool for hepatitis C virus RNA detection and localisation, and for quantification of infected cells. Eur J Histochem. 1998;42:133-136.
22. Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998;42:721-726.
23. Kerkar N, Ma Y, Hussain M et al. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1. J Immunol Methods. 1999;223:227-235.
24. Lenzi M, Bellentani S, Saccoccio G et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut. 1999;45:435-441.
25. Bogdanos DP, Muratori L, Bianchi FB, Vergani D. Hepatitis C virus and autoimmunity. Hepatology. 2000;31:1380.
26. Muratori L, Parola M, Ripalti A et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut. 2000;46:553-561.
27. Muratori L, Gibellini D. A new route to apoptosis in hepatitis C virus infection. J Hepatol. 2001;35:814-815.
28. Muratori L, Muratori P, Zauli D et al. Antilactoferrin antibodies in autoimmune liver disease. Clin Exp Immunol. 2001;124:470-473.
29. Zauli D, Grassi A, Cassani F et al. Autoimmune serology of primary sclerosing cholangitis. Dig Liver Dis. 2001;33:391-392.
30. Muratori L, Sztul E, Muratori P et al. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1. Hepatology. 2001;34:494-501.
31. Muratori P, Muratori L, Cassani F et al. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol. 2002;127:172-175.
32. Varani S, Muratori L, De Ruvo N et al. Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol. 2002;66:56-62.
33. Volta U, Rodrigo L, Granito A et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol. 2002;97:2609-2613.
34. Ma Y, Thomas MG, Okamoto M et al. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol. 2002;169:277-285.
35. Bianchi FB, Muratori P, Muratori L. New autoantibodies and autoantigens in autoimmune hepatitis. Clin Liver Dis. 2002;6:785-797.
36. Muratori P, Muratori L, Agostinelli D et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity. 2002;35:497-500.
37. Muratori P, Loffreda S, Muratori L et al. Spontaneous remission of autoimmune hepatitis during pregnancy. Dig Liver Dis. 2002;34:608-609.
38. Muratori L, Cassani F, Pappas G et al. The hepatitic/cholestatic “overlap” syndrome: an Italian experience. Autoimmunity. 2002;35:565-568.
39. Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol. 2003;132:473-476.
40. Muratori P, Muratori L, Ferrari R et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003;98:431-437.
41. Kerkar N, Choudhuri K, Ma Y et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003;170:1481-1489.
42. Loffreda S, Muratori P, Muratori L, Mele L, Bianchi FB, Lenzi M. Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients. J Hepatol. 2003;38:230-236.
43. Bortolotti F, Muratori L, Jara P et al. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr. 2003;142:185-190.
44. Muratori P, Muratori L, Verucchi G, Attard L, Bianchi FB, Lenzi M. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis. 2003;37:1320-1326.
45. Muratori P, Muratori L, Stroffolini T et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol. 2003;131:118-121.
